We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-20.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$1.64B
AUM Growth
+$440M
Cap. Flow
+$940M
Cap. Flow %
57.18%
Top 10 Hldgs %
44.47%
Holding
4,515
New
888
Increased
1,264
Reduced
882
Closed
1,360

Sector Composition

Rank Sector Weight
1 Financials 4.56%
2 Industrials 3.56%
3 Consumer Discretionary 3.21%
4 Technology 3.1%
5 Healthcare 2.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECS icon
1826
Direxion Daily Technology Bear 3x ETF
TECS
$63.5M
0
TIGO icon
1827
Millicom
TIGO
$15.9B
$16K ﹤0.01%
+572
New +$24K
USO icon
1828
United States Oil Fund
USO
$1.8B
$16K ﹤0.01%
463
-649
-58% -$50K
VOE icon
1829
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$16K ﹤0.01%
200
-3,387
-94% -$365K
XENE icon
1830
Xenon Pharmaceuticals
XENE
$6.11B
$16K ﹤0.01%
1,450
-3,556
-71% -$50.6K
NGM
1831
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$16K ﹤0.01%
+1,324
New +$21.6K
JAX
1832
DELISTED
J. Alexander's Holdings, Inc.
JAX
$16K ﹤0.01%
4,025
+2,199
+120% +$18K
PRVL
1833
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$16K ﹤0.01%
1,353
-2,853
-68% -$45.4K
GSB
1834
DELISTED
GlobalSCAPE, Inc.
GSB
$16K ﹤0.01%
2,247
-1,564
-41% -$14.3K
AEG icon
1835
Aegon
AEG
$13.9B
$15K ﹤0.01%
6,379
-12,263
-66% -$40.9K
CLLS
1836
Cellectis
CLLS
$291M
$15K ﹤0.01%
1,631
+1,478
+966% +$22K
DBVT
1837
DBV Technologies
DBVT
$885M
$15K ﹤0.01%
+370
New +$33.2K
EPHE icon
1838
iShares MSCI Philippines ETF
EPHE
$147M
$15K ﹤0.01%
641
+341
+114% +$10.1K
GTX icon
1839
Garrett Motion
GTX
$5.43B
$15K ﹤0.01%
5,221
-273
-5% -$1.99K
IDN icon
1840
Intellicheck
IDN
$76.3M
$15K ﹤0.01%
+4,471
New +$33.8K
NEXA icon
1841
Nexa Resources
NEXA
$1.91B
$15K ﹤0.01%
4,210
+4,110
+4,110% +$29K
PEN icon
1842
Penumbra
PEN
$12.9B
$15K ﹤0.01%
93
-329
-78% -$55.4K
QNCX icon
1843
Quince Therapeutics
QNCX
$33.3M
$15K ﹤0.01%
+2
New +$19.7K
REPL icon
1844
Replimune Group
REPL
$1.15B
$15K ﹤0.01%
+1,491
New +$22.2K
RGEN icon
1845
Repligen
RGEN
$9.3B
$15K ﹤0.01%
157
-2,465
-94% -$238K
RICK icon
1846
RCI Hospitality Holdings
RICK
$210M
$15K ﹤0.01%
+1,490
New +$26.5K
RLGT icon
1847
Radiant Logistics
RLGT
$391M
$15K ﹤0.01%
3,942
+2,287
+138% +$10.6K
SFM icon
1848
Sprouts Farmers Market
SFM
$7.87B
$15K ﹤0.01%
+797
New +$13.4K
SPNS
1849
DELISTED
Sapiens International
SPNS
$15K ﹤0.01%
767
-77
-9% -$1.75K
TPST icon
1850
Tempest Therapeutics
TPST
$18.9M
$15K ﹤0.01%
15
-16
-52% -$23.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2020 Portfolio in Review

As of Q1 2020, Tower Research Capital (TRC) held 4,515 positions worth $1.64B, up 37% from $1.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tower Research Capital (TRC) deployed $940M of net new capital in Q1 2020, opening 888 new positions and adding to 1,264 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 2.5% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $87.2M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2020 buy was Vanguard S&P 500 ETF: 161,566 shares worth $38.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $101M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $87.2M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q1 2020, selling an estimated $19.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 44% of its $1.64B portfolio in Q1 2020.
  • Tower Research Capital (TRC) opened 888 new positions and closed 1,360 in Q1 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 37% quarter-over-quarter to $1.64B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2020, filed 15 May 2020.